
Curaleaf Holdings (CSE:CURA)

- Symbol:CSE:CURA
- Sector:Healthcare
- Industry:Pharmaceutical
- CEO:Joseph Lusardi
- Founded:2010
Categories:
Curaleaf Holdings (CSE:CURA) Stock Price
Disclaimer: Past performance is not an indicator of future performance.
Curaleaf Holdings (CSE:CURA) Company Overview
Curaleaf Holdings, Inc. (OTCQX: CURLF) currently operates in 12 states with 44 dispensaries, 12 cultivation sites and 11 processing sites.
Most recently this August, the company purchased the Glendale Greenhouse, a 20,000 square-foot, multi-level cultivation center capable of producing 3,600 pounds of flower annually. The facility also operates a state-of-the-art CO2 extraction lab and a kitchen, which is already producing various edible lines such as mints, gummies, brownies and ice cream, with additional products expected to launch later this year.
Curaleaf's house of brands spans across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand and Bido brand for pets.
- Website:https://www.curaleaf.com/
- Address:Suite 405, 301 Edgewater Place, Wakefield, MA 01880, USA
Curaleaf Holdings (CSE:CURA) Financials
Latest Curaleaf Holdings News
More From Curaleaf Holdings...
Stay updated about
this company
Signup to get updates.
Management
At Curaleaf, Mr. Lusardi has been instrumental in developing an organizational strategy focused on bringing the Company’s commitment to the advancement of cannabis science to all Curaleaf subsidiaries, and, ultimately, patients in need of medical cannabis.